S. Bowden

4.6k total citations
58 papers, 1.9k citations indexed

About

S. Bowden is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, S. Bowden has authored 58 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 21 papers in Hepatology and 20 papers in Oncology. Recurrent topics in S. Bowden's work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (21 papers) and Breast Cancer Treatment Studies (10 papers). S. Bowden is often cited by papers focused on Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (21 papers) and Breast Cancer Treatment Studies (10 papers). S. Bowden collaborates with scholars based in United Kingdom, Australia and United States. S. Bowden's co-authors include Stephen Locarnini, Helena Earl, Daniel Rea, Louise Hiller, Glenn Sherman, Hua Xin, John E. Newbold, Janet Dunn, Carlos Caldas and Paul D.P. Pharoah and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

S. Bowden

58 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Bowden United Kingdom	22	810	713	568	391	283	58	1.9k
Brittany L. Murphy United States	21	1.3k 1.6×	667 0.9×	550 1.0×	601 1.5×	933 3.3×	74	3.6k
Stephen A. Geller United States	32	1.4k 1.8×	1.1k 1.5×	598 1.1×	217 0.6×	833 2.9×	127	4.2k
Jordi Guardiola Spain	30	427 0.5×	986 1.4×	481 0.8×	170 0.4×	433 1.5×	143	2.6k
Der‐Cherng Liang Taiwan	21	395 0.5×	1.2k 1.6×	944 1.7×	129 0.3×	150 0.5×	81	2.6k
Yeon Seok Seo South Korea	25	466 0.6×	1.0k 1.5×	1.2k 2.1×	219 0.6×	395 1.4×	141	2.3k
John Kim Canada	27	773 1.0×	221 0.3×	491 0.9×	163 0.4×	815 2.9×	66	2.6k
Mechteld C. de Jong United States	25	1.7k 2.1×	523 0.7×	1.4k 2.5×	170 0.4×	782 2.8×	59	3.1k
François Lefrère France	26	822 1.0×	362 0.5×	503 0.9×	49 0.1×	211 0.7×	79	2.9k
Sandip Kapur United States	29	324 0.4×	383 0.5×	361 0.6×	59 0.2×	373 1.3×	88	2.8k
Nermin Halkic Switzerland	30	596 0.7×	466 0.7×	721 1.3×	86 0.2×	604 2.1×	157	2.7k

Countries citing papers authored by S. Bowden

Since Specialization

Citations

This map shows the geographic impact of S. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bowden more than expected).

Fields of papers citing papers by S. Bowden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bowden. The network helps show where S. Bowden may publish in the future.

Co-authorship network of co-authors of S. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bowden. A scholar is included among the top collaborators of S. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bowden. S. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fernando, Indrajit, Siân Lax, S. Bowden, et al.. (2023). Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity. Clinical Oncology. 35(6). 397–407. 1 indexed citations

Wason, James, Munyaradzi Dimairo, Katie Biggs, et al.. (2022). Practical guidance for planning resources required to support publicly-funded adaptive clinical trials. BMC Medicine. 20(1). 254–254. 6 indexed citations

Veenith, Tonny, Benjamin A. Fisher, Daniel Slade, et al.. (2021). CATALYST trial protocol: a multicentre, open-label, phase II, multiarm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults. BMJ Open. 11(11). e050202–e050202. 3 indexed citations

Fernando, Indrajit, S. Bowden, Cassandra Brookes, et al.. (2019). Synchronous versus sequential chemo-radiotherapy in patients with early stage breast cancer (SECRAB): A randomised, phase III, trial. Radiotherapy and Oncology. 142. 52–61. 10 indexed citations

Meade, Susanna, Piers Gaunt, A. Hartley, et al.. (2018). Feasibility of Dose-escalated Hypofractionated Chemoradiation in Human Papilloma Virus-negative or Smoking-associated Oropharyngeal Cancer. Clinical Oncology. 30(6). 366–374. 10 indexed citations

Dorling, Leila, Siddhartha Kar, Kyriaki Michailidou, et al.. (2016). The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study. PLoS ONE. 11(7). e0158984–e0158984. 8 indexed citations

Abraham, Jean, Louise Hiller, Leila Dorling, et al.. (2015). A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities. BMC Medicine. 13(1). 306–306. 25 indexed citations

Abraham, Jean, Qi Guo, Leila Dorling, et al.. (2014). Replication of Genetic Polymorphisms Reported to Be Associated with Taxane-Related Sensory Neuropathy in Patients with Early Breast Cancer Treated with Paclitaxel. Clinical Cancer Research. 20(9). 2466–2475. 82 indexed citations

Rea, Daniel, Richard Gray, S. Bowden, et al.. (2013). Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer. European Journal of Cancer. 49. 17 indexed citations

10.

Matin, Rubeta, Piers Gaunt, Deborah L. McCartney, et al.. (2013). Developing a standardized actinic keratosis assessment protocol. Discovery Research Portal (University of Dundee). 1 indexed citations

11.

Carmichael, Amtul R., Amanda Daley, Daniel Rea, & S. Bowden. (2010). Physical activity and breast cancer outcome: A brief review of evidence, current practice and future direction. European Journal of Surgical Oncology. 36(12). 1139–1148. 45 indexed citations

12.

Patterson, Scott J., Jacob George, Simone I. Strasser, et al.. (2010). Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut. 60(2). 247–254. 153 indexed citations

13.

Thompson, A., et al.. (2009). 370 SERUM HBeAg AND HBsAg CONCENTRATIONS: CHANGING LEVELS DURING THE NATURAL HISTORY OF CHRONIC HEPATITIS B. Journal of Hepatology. 50. S141–S141. 1 indexed citations

14.

Poustchi, Hossein, Ashraf Mohamadkhani, S. Bowden, et al.. (2008). Clinical significance of precore and core promoter mutations in genotype D hepatitis B‐related chronic liver disease. Journal of Viral Hepatitis. 15(10). 753–760. 39 indexed citations

15.

Hiller, Louise, et al.. (2007). Questioning specialists’ attitudes to breast cancer follow-up in primary care. Annals of Oncology. 18(9). 1467–1476. 49 indexed citations

16.

Haqshenas, Gholamreza, Xuebin Dong, Gary Ewart, S. Bowden, & Eric J. Gowans. (2006). A 2a/1b full-length p7 inter-genotypic chimeric genome of hepatitis C virus is infectious in vitro. Virology. 360(1). 17–26. 18 indexed citations

17.

Newbold, John E., et al.. (1995). The covalently closed duplex form of the hepadnavirus genome exists in situ as a heterogeneous population of viral minichromosomes. Journal of Virology. 69(6). 3350–3357. 246 indexed citations

18.

Su, Chen‐Yao, et al.. (1995). Detection of Hepatitis B Virus DNA in Tears by Polymerase Chain Reaction. Ophthalmic Plastic and Reconstructive Surgery. 11(2). 149–149. 1 indexed citations

19.

Hutchesson, A C J, Susan V. Hughes, S. Bowden, & W A Ratcliffe. (1994). In vitro Stability of Endogenous Parathyroid Hormone-Related Protein in Blood and Plasma. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 31(1). 35–39. 13 indexed citations

20.

Ratcliffe, W A, et al.. (1992). Production and characterisation of monoclonal antibodies to the mid-region 37–67 sequence of parathyroid hormone-related protein. Journal of Immunological Methods. 146(1). 33–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact